Tag: breast cancer

May 10, 2019

Genetic Technologies Completes Two Genetic Risk Tests for Colorectal and Breast Cancer

Genetic Technologies (NASDAQ:GENE, ASX:GTG), has announced two new cancer risk assessments, branded ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast...
April 2, 2019

Hemispherx Announces First Participant Received Initial Dosing in Breast Cancer Clinical Trial

Hemispherx (NYSE American:HEB) has announced the active initiation of a clinical trial sponsored by Roswell Park Comprehensive Cancer Center, evaluating...
March 14, 2019

Atossa Genetics Soars on FDA Expanded Access Program Approval

Shares of Atossa Genetics were up over 368 percent on Thursday to close at US$7.07 following the approval from the...
July 3, 2018

4 Top Biotech Stocks on the TSX of Q2 2018

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
May 23, 2018

Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO

The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
May 7, 2018

Rexahn Reports First Quarter 2018 Financial Results

Rexahn Pharmaceuticals (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced financial...